According to the Low Dose Naltrexone home page [LDN], LDN has been seen to benefit
many different neurodegenerative diseases associated with autoimmune processes, including
Multiple Sclerosis and Parkinson's Disease.
Although Dr. Weyrich is not aware of any reports of treating multiple systems atrophy using
LDN, Dr. Weyrich speculates that multiple systems atrophy may also respond to LDN.
Dr. Weyrich has been trained to use Low Dose Naltrexone (LDN).
However, Dr. Weyrich has not treated any cases of multiple systems atrophy
with LDN.
Please see What is Low Dose Naltrexone?
for more information.
Neuro Research [Hinz2015] reports that
other chronic degenerative neural diseases
can be benefited by balancing neurotransmitter levels in the body.
Dr. Weyrich has been trained in neurotransmitter balancing protocols, but has not treated
Multiple Systems Atrophy using this technique.
Please see What is Neurotransmitter Balancing?
for more information.